Medicines Discovery Catapult Email Format
Research ServicesEngland, United Kingdom51-200 Employees
Medicines Discovery Catapult is a UK-based research services organisation that partners with medicines discovery and diagnostics organisations to provide access to expertise, data, and technology platforms. It supports partners by delivering high-quality data and specialized capabilities aimed at accelerating their work in drug discovery. By enabling collaboration and rapid data-driven decision making, the company helps move precision medicines toward clinical trials more quickly, with the goal of delivering new therapies to patients sooner. Its clients include pharmaceutical and biotech companies and diagnostics developers seeking external capability to advance their programmes. Located in Alderley Park, England, Medicines Discovery Catapult focuses on enabling progress across the medicines discovery pipeline through collaborative, data-supported work. A recent development noted in September 2025 is an integration with CrownBio Inc., combining MDC's radiochemistry and imaging capabilities with CrownBio's preclinical oncology expertise to offer an integrated solution for oncology researchers.